• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Early with Terli in Patients with ACLF and AKI Rapidly Reverses Renal Injury.

作者信息

Avadhanam Mahathi, Kulkarni Anand V

机构信息

Department of Critical Care, Queen Elizabeth Hospital, London, UK.

Department of Hepatology, AIG Hospitals, Hyderabad, India.

出版信息

Dig Dis Sci. 2024 Oct;69(10):3594-3596. doi: 10.1007/s10620-024-08653-w. Epub 2024 Sep 30.

DOI:10.1007/s10620-024-08653-w
PMID:39349904
Abstract
摘要

相似文献

1
Early with Terli in Patients with ACLF and AKI Rapidly Reverses Renal Injury.早期使用特尔利治疗急性肝衰竭合并急性肾损伤患者可迅速逆转肾损伤。
Dig Dis Sci. 2024 Oct;69(10):3594-3596. doi: 10.1007/s10620-024-08653-w. Epub 2024 Sep 30.
2
Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure-acute kidney injury - an open label RCT.特利加压素静脉输注与推注治疗慢性肝衰竭急性肾损伤患者的比较——一项开放标签随机对照试验
Clin Exp Hepatol. 2023 Dec;9(4):351-358. doi: 10.5114/ceh.2023.132813. Epub 2023 Dec 5.
3
Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure.评价急性肾损伤及其对慢性肝衰竭患者特利加压素的反应。
Liver Int. 2016 Jan;36(1):59-67. doi: 10.1111/liv.12895. Epub 2015 Sep 18.
4
AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis.在伴有慢加急性肝衰竭的患者中，急性肾损伤与肝硬化急性失代偿不同。
Hepatol Int. 2015 Oct;9(4):627-39. doi: 10.1007/s12072-015-9653-x. Epub 2015 Sep 2.
5
[Comparison of clinical features between patients with acute-on-chronic liver failure and decompensated liver cirrhosis combined with acute kidney injury].急性-on-慢性肝衰竭患者与失代偿期肝硬化合并急性肾损伤患者临床特征的比较
Zhonghua Gan Zang Bing Za Zhi. 2020 May 20;28(5):391-396. doi: 10.3760/cma.j.cn501113-20200417-00192.
6
Acute Kidney Injury at Admission Is a Better Predictor of Mortality than Its Persistence at 48 h in Patients with Acute-on-chronic Liver Failure.在慢性肝功能衰竭急性发作患者中，入院时的急性肾损伤比48小时时的持续性急性肾损伤更能预测死亡率。
J Clin Transl Hepatol. 2018 Dec 28;6(4):396-401. doi: 10.14218/JCTH.2018.00035. Epub 2018 Dec 3.
7
Intermittent high-flux albumin dialysis with continuous venovenous hemodialysis for acute-on-chronic liver failure and acute kidney injury.间断性高通量白蛋白透析联合连续性静脉-静脉血液透析治疗慢加急性肝衰竭合并急性肾损伤。
Artif Organs. 2020 Jan;44(1):91-99. doi: 10.1111/aor.13532. Epub 2019 Jul 22.
8
Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.急慢性肝衰竭中的急性肾损伤与失代偿性肝硬化中的不同。
World J Gastroenterol. 2018 Jun 7;24(21):2300-2310. doi: 10.3748/wjg.v24.i21.2300.
9
Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study).急性肝肾衰竭中特利加压素早期与标准起始治疗急性肾损伤：一项随机对照试验(eTerli 研究)。
Dig Dis Sci. 2024 Jun;69(6):2204-2214. doi: 10.1007/s10620-024-08423-8. Epub 2024 Apr 18.
10
Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure.胱抑素 C 是预测急性肝衰竭患者急性肾损伤的生物标志物。
World J Gastroenterol. 2013 Dec 28;19(48):9432-8. doi: 10.3748/wjg.v19.i48.9432.

本文引用的文献

1
Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study).急性肝肾衰竭中特利加压素早期与标准起始治疗急性肾损伤：一项随机对照试验(eTerli 研究)。
Dig Dis Sci. 2024 Jun;69(6):2204-2214. doi: 10.1007/s10620-024-08423-8. Epub 2024 Apr 18.
2
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting.肝硬化患者的急性肾损伤：急性疾病质量倡议 (ADQI) 和国际腹水俱乐部 (ICA) 联合多学科共识会议。
J Hepatol. 2024 Jul;81(1):163-183. doi: 10.1016/j.jhep.2024.03.031. Epub 2024 Mar 26.
3
Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography.
应用床旁超声心动图评估肝肾综合征-急性肾损伤患者特利加压素相关治疗结局。
Hepatology. 2024 May 1;79(5):1048-1064. doi: 10.1097/HEP.0000000000000691. Epub 2023 Nov 16.
4
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI).特利加压素治疗肝肾功能衰竭急性肾损伤（HRS-AKI）成人患者。
Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(11):1067-1079. doi: 10.1080/17474124.2023.2273494. Epub 2023 Nov 23.
5
Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.特利加压素治疗伴有肝肾综合征-急性肾损伤（HRS-AKI）的慢加急性肝衰竭患者的安全性和有效性：一项前瞻性队列研究。
Sci Rep. 2022 Apr 1;12(1):5503. doi: 10.1038/s41598-022-09505-1.
6
Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis.全球疾病负担：慢性肝衰竭急性发作，系统评价和荟萃分析。
Gut. 2022 Jan;71(1):148-155. doi: 10.1136/gutjnl-2020-322161. Epub 2021 Jan 12.
7
Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives.特利加压素经受住了时间的考验：2020年临床概述及未来展望。
Liver Int. 2020 Dec;40(12):2888-2905. doi: 10.1111/liv.14703.
8
Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.特利加压素持续静脉输注与静脉推注治疗肝肾综合征的随机对照研究。
Hepatology. 2016 Mar;63(3):983-92. doi: 10.1002/hep.28396. Epub 2016 Feb 3.